StockData
Xencor Inc logo

Xencor Inc (XNCR) shareholders

XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)

Close on Nov 18, 2026Market cap $2.56BP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
100.0%
84M of 74M shares
Institutional holders
208
33 new, 24 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 21 sales
Net sold $7.49M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.10,816,41714.50%13G (passive) amendmentSep 30, 2026
Primecap Management Co/Ca/9,879,85513.29%13G (passive) amendmentSep 30, 2026
Lampert Mark N
Joint filing with Bvf Partners L P/Il (9.99%), Bvf Inc/Il (9.99%) and 3 more
7,133,7209.99%13G (passive) amendmentDec 31, 2025
Roderick Wong
Joint filing with RTW Investments, LP (8.70%)
6,221,0548.70%13G (passive)Sep 30, 2025
Rajeev Shah
Joint filing with RA Capital Management, L.P. (6.50%), Peter Kolchinsky (6.50%) and 1 more
4,736,7396.50%13G (passive)Mar 23, 2026
Oleg Nodelman
Joint filing with EcoR1 Capital, LLC (6.40%), EcoR1 Capital Fund Qualified, L.P. (6.00%)
4,640,0006.40%13G (passive) amendmentDec 31, 2025
State Street Corporation4,507,2546.30%13G (passive)Dec 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of XNCRValueChange% of portfolio
BlackRock, Inc.13,651,26118.36%$219.79M+615,3430.00%
Primecap Management Co/Ca/10,181,32213.69%$163.92M−156,7000.10%
Bvf Inc/Il7,133,7209.59%$114.85M–2.94%
Rtw Investments, LP6,777,4619.12%$109.12M–0.93%
Ra Capital Management, L.P.5,274,2747.09%$84.92M+377,0370.74%
State Street Corp4,954,0166.66%$79.76M+601,9800.00%
Vanguard Capital Management LLC3,278,8024.41%$52.79M+177,1550.00%
TCG Crossover Management, LLC2,452,1383.30%$39.48M–0.95%
Price T Rowe Associates Inc /Md/2,356,4093.17%$37.94M+795,9890.00%
Vanguard Portfolio Management LLC2,215,6902.98%$35.67M−1,284,6520.00%
Geode Capital Management, LLC1,920,8592.58%$30.93M+105,2820.00%
Morgan Stanley1,752,5562.36%$28.22M+194,2660.00%
UBS Group AG1,306,1741.76%$21.03M+223,7550.00%
Baker Bros. Advisors LP1,102,1061.48%$17.74M–0.09%
Legal & General Group Plc1,091,1771.47%$17.57M+24,3970.00%
Dimensional Fund Advisors LP1,011,1191.36%$16.28M−283,7680.00%
Goldman Sachs Group Inc968,7781.30%$15.60M+204,9850.00%
Millennium Management LLC853,6771.15%$13.74M+243,8890.00%
Two Sigma Investments, LP819,5151.10%$13.19M+14,0940.01%
Northern Trust Corp794,2791.07%$12.79M+49,7600.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202620884M100.0%33 / 8456 / 247M7M
Q1 202620384M100.0%26 / 7065 / 2816M6M
Q4 202520882M100.0%35 / 6078 / 2812M12M
Q3 202520682M100.0%34 / 5681 / 1910M12M
Q2 202519384M100.0%24 / 9238 / 3211M6M
Q1 202520279M100.0%35 / 7067 / 258M3M
Q4 202419375M100.0%24 / 8255 / 4010M8M
Q3 202421072M97.2%39 / 5882 / 2624M6M
Q2 202419865M87.8%25 / 6570 / 255M6M
Q1 202420167M89.8%32 / 7168 / 239M7M
Q4 202319565M87.0%35 / 7657 / 177M6M
Q3 202317863M85.4%20 / 5976 / 233M2M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

230 funds held XNCR in Q2 2026, 49% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of XNCRValue% of fundAs of
PRIMECAP Odyssey Aggressive Growth Fund6,335,3778.52%$128.04M1.73%Jul 31, 2026
iShares Core S&P Small-Cap ETF4,452,4365.99%$71.68M0.06%Jun 30, 2026
PRIMECAP Odyssey Growth Fund3,098,0004.17%$62.61M1.03%Jul 31, 2026
Vanguard Total Stock Market Index Fund2,341,9883.15%$37.71M0.00%Jun 30, 2026
State Street(R) SPDR(R) S&P(R) Biotech ETF1,939,6702.61%$31.23M0.29%Jun 30, 2026
iShares Russell 2000 ETF1,818,5132.45%$29.28M0.04%Jun 30, 2026
Vanguard Extended Market Index Fund860,7821.16%$13.86M0.01%Jun 30, 2026
Fidelity Small Cap Index Fund761,3391.02%$15.39M0.05%Jul 31, 2026
State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF683,0230.92%$11.00M0.07%Jun 30, 2026
iShares Russell 2000 Value ETF647,7650.87%$10.43M0.07%Jun 30, 2026
iShares S&P Small-Cap 600 Value ETF637,2380.86%$10.26M0.13%Jun 30, 2026
T. Rowe Price New Horizons Fund, Inc.634,3000.85%$10.21M0.07%Jun 30, 2026
Vanguard Explorer Fund592,1790.80%$11.97M0.05%Jul 31, 2026
BlackRock Advantage Small Cap Core Fund532,9120.72%$6.33M0.12%May 29, 2026
iShares Biotechnology ETF492,9230.66%$7.94M0.09%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Bassil I. DahiyatPRESIDENT & CEO, Director546,3160.73%Mar 9, 2026
Bart Jan CornelissenSR. VICE PRESIDENT & CFO65,7980.09%Nov 12, 2026
John R. DesjarlaisSR. VICE PRESIDENT & CSO263,8310.35%Mar 9, 2026
Celia EckertSVP, GENERAL COUNSEL76,9180.10%Mar 9, 2026
Nancy ValenteEVP, Chief Development Officer49,1690.07%May 6, 2025
Richard J. RanieriDirector18,5140.02%Nov 12, 2026
Todd E. SimpsonDirector23,9880.03%Jul 8, 2026
Ellen FeigalDirector22,6420.03%Jul 8, 2026
Alan Bruce MontgomeryDirector25,8490.03%Jul 8, 2026
Kurt A. GustafsonDirector25,0110.03%Jul 8, 2026
Raymond Joseph DeshaiesDirector10,3020.01%Jul 8, 2026
Barbara KlenckeDirector29,9740.04%Jul 8, 2026
Kevin Charles GormanDirector21,6800.03%Jul 8, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Bart Jan Cornelissen
SR. VICE PRESIDENT & CFO
Nov 11, 2026Sale−10,100$39.82$402.18K65,798
Richard J. Ranieri
Director
Nov 10, 2026Sale−11,172$39.59$442.30K18,514
Richard J. Ranieri
Director
Nov 10, 2026Sale−70,080$39.20$2.75M29,686
Richard J. Ranieri
Director
Nov 10, 2026Option exercise+27,372$9.43$258.12K99,766
Richard J. Ranieri
Director
Nov 10, 2026Option exercise+11,971$21.31$255.10K72,394
Richard J. Ranieri
Director
Nov 10, 2026Option exercise+21,412$26.58$569.13K60,423
Richard J. Ranieri
Director
Nov 10, 2026Option exercise+15,000$23.04$345.60K39,011
Ellen Feigal
Director
Jun 18, 2026Sale(10b5-1 plan)−6,843$13.06$89.37K12,340
Todd E. Simpson
Director
Jun 16, 2026Award+10,302––23,988
Ellen Feigal
Director
Jun 16, 2026Award+10,302––22,642
Barbara Klencke
Director
Jun 16, 2026Award+10,302––29,974
Richard J. Ranieri
Director
Jun 16, 2026Award+10,302––24,011
Kevin Charles Gorman
Director
Jun 16, 2026Award+10,302––21,680
Raymond Joseph Deshaies
Director
Jun 16, 2026Award+10,302––10,302
Kurt A. Gustafson
Director
Jun 16, 2026Award+10,302––25,011
Alan Bruce Montgomery
Director
Jun 16, 2026Award+10,302––25,849
Alan Bruce Montgomery
Director
Jun 15, 2026Sale(10b5-1 plan)−5,064$12.31$62.34K15,547
Kevin Charles Gorman
Director
Jun 15, 2026Sale(10b5-1 plan)−7,527$12.31$92.66K11,378
Kurt A. Gustafson
Director
Jun 15, 2026Sale(10b5-1 plan)−5,474$12.31$67.38K14,709
Richard J. Ranieri
Director
Jun 15, 2026Sale(10b5-1 plan)−5,474$12.31$67.38K13,709
Bart Jan Cornelissen
SR. VICE PRESIDENT & CFO
Apr 10, 2026Sale−3,499$12.29$43.00K75,898
John R. Desjarlais
SR. VICE PRESIDENT & CSO
Mar 6, 2026Sale−2,502$11.02$27.57K263,831
Bassil I. Dahiyat
PRESIDENT & CEO, Director
Mar 6, 2026Sale−6,606$11.02$72.80K546,316
Celia Eckert
SVP, GENERAL COUNSEL
Mar 6, 2026Sale−1,767$11.02$19.47K76,918
John R. Desjarlais
SR. VICE PRESIDENT & CSO
Mar 5, 2026Sale−4,118$11.25$46.33K266,333
Bassil I. Dahiyat
PRESIDENT & CEO, Director
Mar 5, 2026Sale−14,870$11.25$167.29K552,922
Celia Eckert
SVP, GENERAL COUNSEL
Mar 5, 2026Sale−3,244$11.25$36.50K78,685
Bart Jan Cornelissen
SR. VICE PRESIDENT & CFO
Mar 5, 2026Sale−2,517$11.25$28.32K79,397
Bassil I. Dahiyat
PRESIDENT & CEO, Director
Mar 3, 2026Sale−6,758$11.90$80.42K567,792
Celia Eckert
SVP, GENERAL COUNSEL
Mar 3, 2026Sale−1,492$11.90$17.75K81,929
John R. Desjarlais
SR. VICE PRESIDENT & CSO
Mar 3, 2026Sale−2,663$11.90$31.69K270,451
Bassil I. Dahiyat
PRESIDENT & CEO, Director
Mar 2, 2026Award+97,291––574,550
Celia Eckert
SVP, GENERAL COUNSEL
Mar 2, 2026Award+18,680––83,421
John R. Desjarlais
SR. VICE PRESIDENT & CSO
Mar 2, 2026Award+24,907––273,114
Bart Jan Cornelissen
SR. VICE PRESIDENT & CFO
Mar 2, 2026Award+19,458––81,914
John R. Desjarlais
SR. VICE PRESIDENT & CSO
Jan 23, 2026Option exercise+5,322$12.51$66.58K248,207
Bassil I. Dahiyat
PRESIDENT & CEO, Director
Dec 22, 2025Option exercise+10,624$12.51$132.91K477,259
John R. Desjarlais
SR. VICE PRESIDENT & CSO
Dec 22, 2025Option exercise+6,311$12.51$78.95K242,885
Bassil I. Dahiyat
PRESIDENT & CEO, Director
Dec 19, 2025Option exercise+114,377$12.51$1.43M581,012
Bassil I. Dahiyat
PRESIDENT & CEO, Director
Dec 19, 2025Sale−114,377$15.71$1.80M466,635
John R. Desjarlais
SR. VICE PRESIDENT & CSO
Dec 19, 2025Option exercise+73,367$12.51$917.82K309,941
John R. Desjarlais
SR. VICE PRESIDENT & CSO
Dec 19, 2025Sale−73,367$15.72$1.15M236,574
Ellen Feigal
Director
Jun 16, 2025Sale(10b5-1 plan)−2,993$9.22$27.60K19,183
Richard J. Ranieri
Director
Jun 16, 2025Sale(10b5-1 plan)−2,993$9.22$27.60K19,183
Kurt A. Gustafson
Director
Jun 16, 2025Sale(10b5-1 plan)−2,993$9.22$27.60K20,183
Kevin Charles Gorman
Director
Jun 16, 2025Sale(10b5-1 plan)−3,173$9.22$29.26K18,905
Alan Bruce Montgomery
Director
Jun 16, 2025Sale(10b5-1 plan)−2,215$9.22$20.42K20,611
Ellen Feigal
Director
Jun 12, 2025Award+13,686––22,176
Richard J. Ranieri
Director
Jun 12, 2025Award+13,686––22,176
Barbara Klencke
Director
Jun 12, 2025Award+13,686––19,672
Todd E. Simpson
Director
Jun 12, 2025Award+13,686––13,686
Kurt A. Gustafson
Director
Jun 12, 2025Award+13,686––23,176
Kevin Charles Gorman
Director
Jun 12, 2025Award+13,686––22,078
Alan Bruce Montgomery
Director
Jun 12, 2025Award+13,686––22,826
Nancy Valente
EVP, Chief Development Officer
May 2, 2025Sale−4,616$11.03$50.91K49,169
Bart Jan Cornelissen
SR. VICE PRESIDENT & CFO
Apr 10, 2025Sale−3,750$8.06$30.23K61,348
Nancy Valente
EVP, Chief Development Officer
Mar 10, 2025Sale−2,565$13.60$34.88K53,785
John R. Desjarlais
SR. VICE PRESIDENT & CSO
Mar 10, 2025Sale−9,697$13.60$131.88K236,574
Bassil I. Dahiyat
PRESIDENT & CEO, Director
Mar 10, 2025Sale−19,716$13.60$268.14K465,419
Celia Eckert
SVP, GENERAL COUNSEL
Mar 10, 2025Sale−5,740$13.60$78.06K63,507

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
17.62%
13M shares short
Days to cover
6.6
At 2M shares a day
Change since last report
+5.1%
From 12M shares
Short volume, 20 days
64.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Xencor's stock actually held short. Settlement fails (shares not delivered on time) peaked at 63,277 shares on Aug 27, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Richard J. Ranieri
Director
Nov 10, 202681,252$3.19MNov 10, 2026Restricted Stock Vesting
Ellen Feigal
Director
Jun 18, 20266,843$89.37KJun 18, 2026Restricted Stock Vesting
Alan Bruce Montgomery
Director
Jun 15, 20265,064$62.34KJun 15, 2026Restricted Stock Vesting
Richard J. Ranieri
Director
Jun 15, 20265,474$67.38KJun 15, 2026Restricted Stock Vesting
Kurt A. Gustafson
Director
Jun 15, 20265,474$67.38KJun 15, 2026Restricted Stock Vesting
Kevin Charles Gorman
Director
Jun 15, 20267,527$92.66KJun 15, 2026Restricted Stock Vesting
Bart Jan Cornelissen
Officer
Apr 10, 20263,499$42.99KApr 10, 2026Restricted Stock Vesting
Celia Eckert
Officer
Mar 6, 20261,767$19.47KMar 6, 2026Restricted Stock Vesting
Bassil I. Dahiyat
Officer, Director
Mar 6, 20266,606$72.80KMar 6, 2026Restricted Stock Vesting
John R. Desjarlais
Officer
Mar 6, 20262,502$27.57KMar 6, 2026Restricted Stock Vesting
Celia Eckert
Officer
Mar 5, 20263,244$36.48KMar 5, 2026Restricted Stock Vesting
Bassil I. Dahiyat
Officer, Director
Mar 5, 202614,870$167.22KMar 5, 2026Restricted Stock Vesting
Bart Jan Cornelissen
Officer
Mar 5, 20262,517$28.30KMar 5, 2026Restricted Stock Vesting
John R. Desjarlais
Officer
Mar 5, 20264,118$46.31KMar 5, 2026Restricted Stock Vesting
Bassil I. Dahiyat
Officer, Director
Mar 3, 20266,758$80.39KMar 3, 2026Restricted Stock Vesting

See a number that looks wrong?